drugset / Trial / NCT01890837

Effect of TU-100 in Patients With Irritable Bowel Syndrome (IBS)

NCT01890837 ↗

Phase 1/2 Completed 40 enrolled Tsumura USA Cato Research · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to compare the effects of 5g of Daikenchuto (TU-100) three times per day (Daikenchuto \[TU-100\] is a botanical agent that modulates gastrointestinal nerves), and placebo on rectal sensation (sensation ratings of urgency to defecate and sensation threshold for pain) in response to rectal balloon distension by barostat in patients with IBS.

Timeline

Start
2013-08
Primary completion
2015-03
Completion
2015-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Daikenchuto Traditional medicine (herbal / TCM) 5 g —